LIGHTNING RELEASES (9/21/2014) – While the Security Council sits and talks, people are dying from Ebola, yet a potential cure for the disease has been completely shunned by authorities.
Cutting edge New Zealand based research company, Regenex Laboratories, claims to have an injectable immune activation product that could potentially solve the Ebola crisis, yet their spokesperson, Mark Linford, says the company has offered it product for a free trial but has been ignored.In the first-ever emergency Security Council meeting called on a health crisis, all 15 council members voted to declare the disease (Ebola) a “threat to international peace and security.” The council met on HIV/AIDS in 2000, in a non-emergency session. On Friday, the General Assembly passed, with all 193 member states in favor, its own resolution on Ebola, after holding open debate on the health crisis. The resolution had the most co-sponsors in UN history: 134. Israel’s Ambassador Ron Prosor addressed the Security Council on Thursday and expressed unequivocal support for sending aid workers and funding to Guinea, Liberia and Sierra Leone.
Regenex Laboratories has developed an injectable product, which assists the body to fight off virally spread pathogens by activating dormant stem cells within the body, restoring the bodies immune system to a fully functional state. The company currently supplies its cutting edge product, Immune Booster IM, for the treatment of HIV, Crohnes Disease and other immune conditions.
Company spokesperson, Mr. Mark Linford, said they had offered up to 30 trial programs (valued at almost $50,000 USD) to the government of West Africa and to Médecins Sans Frontières, but were simply ignored he says.
“We even tried to contact the Al Jazeera network, since they are actively reporting in the area, to try to get them to implore the authorities to try our treatment program, but all to no avail.”
“It’s really a crime that a potential cure sits here waiting for trial yet no-one wants to give it a try. There is one thing that is a scientific certainty – if they don’t use it, it won’t work.” he said
The product is a blend of growth factors, peptides, selected proteins and signaling molecules obtained from ovine placental extract. The patent pending technology assists the stimulation of billions of stem cells in vivo from a quiescent (dormant) state to an active state and has no known side effects. It can also be used in conjunction with other therapies, including anti biotic treatment.
During an appearance on The Daily Show with Jon Stewart last Thursday, former US president Bill Clinton said that the WHO, UN, Médecins Sans Frontières and US Department of Health will speak about Ebola during this year’s Clinton Global Initiative.
More information at http://ift.tt/1wYspIO
The post Potential Ebola Cure Shunned by Authorities appeared first on Lightning Releases.
via Lightning Releases http://ift.tt/1tRa8dP
No comments:
Post a Comment